Iga Nephropathy
What's New
Last Posted: Jun 24, 2024
- Clinical Application of Polygenic Risk Score in IgA Nephropathy.
Linlin Xu, et al. Phenomics (Cham, Switzerland) 2024 0 (2) 146-157 - Combined Genetic Association and Differed Expression Analysis of UBE2L3 Uncovers a Genetic Regulatory Role of (Immuno)proteasome in IgA Nephropathy.
Lin-Lin Xu, et al. Kidney diseases (Basel, Switzerland) 2024 0 (3) 167-180 - Mendelian randomization analysis reveals causal relationships between circulating cell traits and renal disorders.
Xing-Yu Shi, et al. Frontiers in medicine 2024 0 1360868 - Risk factors and outcomes of IgA nephropathy recurrence after kidney transplantation: a systematic review and meta-analysis.
Yue Li, et al. Frontiers in immunology 2023 0 1277017 - Interleukin Variants Are Associated with the Development and Progression of IgA Nephropathy: A Candidate-Gene Association Study and Meta-Analysis.
Ioanna Chronopoulou, et al. International journal of molecular sciences 2023 0 (22) - Candidate Genes for IgA Nephropathy in Pediatric Patients: Exome-Wide Association Study.
Anastasiia A Buianova, et al. International journal of molecular sciences 2023 0 (21) - Genome-Wide Association Analysis of Protein-Coding Variants in IgA Nephropathy.
Ming Li, et al. Journal of the American Society of Nephrology : JASN 2023 0 - Mucosal Immune Defence Gene Polymorphisms as Relevant Players in the Pathogenesis of IgA Vasculitis?
Joao Carlos Batista-Liz, et al. International journal of molecular sciences 2023 0 (17) - Causal associations between thyroid cancer and IgA nephropathy: a Mendelian randomization study.
Ziwei Mei, et al. BMC genomics 2023 0 (1) 525 - Mesangial C3 Deposition, Complement-Associated Variant, and Disease Progression in IgA Nephropathy.
Yuqi Kang, et al. Clinical journal of the American Society of Nephrology : CJASN 2023 0
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: